Ac immune announces pricing of underwritten offering of common shares

Ac immune announces pricing of underwritten offering of common shares lausanne, switzerland, december 15, 2023 – ac immune sa (nasdaq: aciu) (the “company” or “ac immune”), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it has priced an underwritten offering of 14.3 million of its common shares at a price of usd 3.50 per share. the company expects the gross proceeds from the offering, before deducting the underwriting discounts and commissions and other offering expenses, to be approximately usd 50.1 million.
ACIU Ratings Summary
ACIU Quant Ranking